Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorComposite Interceptive Med Science

About this trial

Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients. Livitol-17 consist of the 3 whole herbs and extract which has antioxidant, hepatoprotective as well as reno-protective properties. The aim of this trial is to study the efficacy of herbal supplement to improve the liver function of alcoholic liver disease subject.

Eligibility criteria

Qualifiers

Chronic alcohol intake, Identified with AUDIT(Alcohol Use Disorder Inventory Test) Questionnaire

Active alcohol use until 4 weeks prior to presentation

ALT and AST elevated >1.5 times the upper limit of normal

Over 1.5 ratio of AST to ALT

Disqualifiers

Severe alcoholic hepatitis with cirrhosis or life expectancy less than 3 months

Severe renal impairment (Glomerular filtration rate below 60 ml/min per 1.73m2)

Hepatic disorders due to cardiac causes, inherited metabolic causes, hemochromatosis and Wilson's disease

Participants with active viral hepatitis

Trial design

Treatments tested in this trial

  • Livitol-70

Treatment groups

40 Participants
are divided into 1 treatment group